Vaccine vial maker Stevanato valued at over $5 bln in NYSE debut – Reuters
By Reuters Staff
July 16 (Reuters) – Shares of Italys Stevanato Group S.p.A. , which makes glass vials for COVID-19 vaccines and other healthcare products, fell more than 20% in their New York Stock Exchange debut on Friday, giving the company a market…
